Market Portrayal
A latest report has been added to Market Research
Future's offering in this COVID 19 pandemic that states, the global Whole
Exome Sequencing Market Trends is expected to reach USD 7.8 Billion
by 2032 at CAGR of 20.20% during the forecast period 2023-2032.
Top Players
The global whole exome sequencing market
players are
BGI
(China),
Thermo
Fisher Scientific (US),
F.
Hoffmann-La Roche Ltd (Switzerland),
Agilent
Technologies, Inc. (US),
Ambry
Genetics (US),
Integragen
SA (France), and
Macrogen,
Inc. (South Korea).
Segment Review
Global Whole Exome Sequencing Market is
studied over the segments of product, technology, application, and end user.
The
market, based on product segment, has included
sequencer, kits, and services. Kits segment is further segmented into end
repair, DNA fragmentation, A-tailing, library preparation, size selection kits,
and target enrichment. Services segment is also further sub-segmented into Data
Analysis (Bioinformatics), Sequencing Services, and others.
The
global whole exome sequencing market, by technology segment, has included ION semiconductor sequencing, Sequencing by Synthesis
(SBS), and others.
The
market by application segment has included drug
discovery, diagnostics, agriculture, development, animal research, and others.
Based on
end user segment, the market has included pharmaceutical
& biotechnology companies, hospitals and diagnostics centers, research
centers and government institutes, and others.
Whole Exome Sequencing Drivers &
Trends
The whole-exome sequencing permits
identifying the variations in the protein-coding sites of any gene compared to
sequencing a few genes mutually. The whole-exome sequencing is preferred widely
owing to its property to identify a mutation in a single exon. Identifying
mutation in at the original site makes whole-exome sequencing a capable method
and enables to identify possible disease-causing mutation.
Whole
Exome Sequencing Market Research, Size, Trends and Industry by Product
(Kits (DNA Fragmentation, End Repair, A-Tailing and Size Selection Kits,
Library Preparation, Target Enrichment) Sequencer, Services (Sequencing
Services, Data Analysis, Others) Technology (SBS, ION Semiconductor Sequencing,
Others) Application (Diagnostics (Cancer Diagnostics, Monogenic Disorders,
Monogenic Types Of Diabetes, Others) Drug Discovery And Development,
Agriculture and Animal Research, Others),
The global Whole Exome Sequencing Market
Trends might expand at a rapid pace owing to factors such as rapidly declining
costs of sequencing, research institutes, strategic alliances among major
companies, adoption of WES technology by new consumers, and surge in use of whole
exome sequencing technology for new applications.
Surge in acceptance of next generation
sequencing methods for treatment, prediction, and monitoring of diverse chronic
diseases such as cancer is possible to motivate the market. In fact, the
advancement in the field of genomics has also led to a noteworthy reduction in
the time and cost of genome sequencing.
Apart from this, the associated cost of
sequencing with different sequencing techniques and strategies are of interest
as they persuade the scope and scale of the genomic research studies. Thus, it
makes whole-exome sequencing much-preferred method than whole-genome
sequencing, which has become a well-defined factor for the growth of the
market.
On the contrary, the factor of lack of
skilled professionals and legal issues linked with the technique might restrain
the global whole exome sequencing market. In this case, soaring demand for
personalized medicine and development of new innovative products by top players
offer numerous opportunities for market expansion in the coming years.
Regional Framework
The Americas was the prevalent market for
whole exome sequencing in the year 2019. The growth of the Americas market
happened owing to the towering prevalence rate of cancer and other chronic
disorders and rising healthcare expenditure. Additionally, favorable
initiatives by the government and other organizations for the development and
adoption of whole-exome sequencing technologies are motivating the market for
whole-exome sequencing. In the case of point, in the year 2018, All of Us
Research Program, a part of the National Institutes of Health, awarded funds
over USD 28.6 million to launch three genome centers in the US. These centers
intend to produce genome data for researchers and the program’s precision
medicine research platform, a national resource to support studies on a variety
of important health questions.
Europe is the second-prime market for whole
exome sequencing. Western Europe holds the leading market share. The European
market might record a muscular growth rate during the forecast period owing to
intensifying cases of cancer and rising programs for the adoption of genome
sequencing. As per the International Agency for Research on Cancer, in the year
2018, there were about 4,229,662 cases of cancer in Europe. These huge cases of
cancer and rising genome mapping programs might have a positive impact on the
expansion of the whole-exome sequencing market.
Asia-Pacific might represent the maximum
market growth potential over the forecast period owing to the increasing
patient pool and rising technological advancements. The fast growth of the
Asia-Pacific region is owing to the mounting per capita income along with
government initiatives to enhance the quality of healthcare. China, India, and
Australia have a rewarding market for Whole Exome Sequencing owing to the
growing older population.
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
